• Explore /
  • Poster
  • / Reversion of <em>RAS</em> mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial.

Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial.

Abstract Poster

Authors

null

Florence T.H. Wu

University of British Columbia & BC Cancer, Vancouver, BC, Canada

Florence T.H. Wu , James T. Topham , Christopher J. O'Callaghan , Harriet Feilotter , Hagen Fritz Kennecke , Kimberly Banks , Daniel John Renouf , Derek J. Jonker , Dongsheng Tu , Eric Xueyu Chen , Jonathan M. Loree

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT02870920

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3567)

DOI

10.1200/JCO.2023.41.16_suppl.3567

Abstract #

3567

Poster Bd #

267

Abstract Disclosures

Similar Posters

First Author: Tanya Jindal

First Author: Kanwal Pratap Singh Raghav

First Author: Philip C. Mack

First Author: Reagan Barnett